期刊文献+

p27及p16蛋白在口腔鳞癌中的表达和意义

The expression of p27 and p16 protein in oral squamous cell carcinoma
原文传递
导出
摘要 目的 探讨 p2 7与p16基因产物在口腔鳞癌和癌旁组织中的表达 ,了解 p2 7与 p16在口腔鳞癌发生中的意义。方法 采用 p2 7与 p16单克隆抗体 ,用免疫组化S -P法对 3 7例口腔鳞癌组织、3 0例癌旁组织、10例正常口腔黏膜 p2 7与p16的表达进行检测 ,结果 p2 7与 p16表达减少与口腔鳞癌的发生和恶性程度有关。p2 7表达下降与临床分期有关 ,p16与临床分期无关。p2 7与 p16在口腔鳞癌中表达无关 ,但在口腔鳞癌中表达随恶性程度的增高而降低。结论 p2 7与 p16蛋白有可能作为有价值的标志物 ,在口腔鳞癌的诊断、治疗、预后判断中起辅助作用。 Objective To investigate the expressions of p27 and p16 protein in o ral squamous cell carcinomas (OSCC) and pericancerous mucosas in order to study the role and relationship of p27 and p16 protein in oral carcinogenesis. Method Immunohistochemical S-P method was used in this study to dete ct the expressions of p27 and p16 protein in 37 OSCCs, 30 pericancerous mucosas and 10 normal oral mucosas .Result The reduced expressions of p27 and p16 were related to the d evelopment and extent of malignancy of OSCCs. The expression of p27 was related to clinical stages, while that of p16 was not. p27 was not related to p16 in the ir expressions; but both of them decreased with the increasing extent of maligna ncy.Conclusion Both p27 and p16 could be used in diagnosis, th erapy and prognosis as an assistant marker.
出处 《临床口腔医学杂志》 2003年第7期397-399,共3页 Journal of Clinical Stomatology
关键词 P27 P16 口腔鳞癌 表达 免疫组织化学 immunohistochemistry p27 p16 oral squamous ce ll carcinoma
  • 相关文献

参考文献4

  • 1王炼,卢勇,魏于全,吴兰雁,杨橙,蔡益新.P27蛋白在牙源性肿瘤的表达[J].华西口腔医学杂志,1998,16(1):10-11. 被引量:5
  • 2赵明,李野,孙立群,郭丽娟,许亚辉.喉癌组织中P16的免疫组化定量分析[J].白求恩医科大学学报,2000,26(4):382-384. 被引量:3
  • 3Saito T, Nakajima T, et al.Immunohistochemical analysis of cell cyclinassociated protein p16, PRb, p53, p27andKi - 67 in oral cancer and precancer with special reference to verrucous carcinomas[ J ]. J Oral Pathol Med, 1999,28:226-32.
  • 4Reed A, Califano J, Cairns P, et al. High frequency of p16 (CD -KN2/MTS- 1/INK4A) inactivation in head and neck squamous cell carcinoma [J]. Cancer Rea, 1996,56:3630--3633.

二级参考文献8

  • 1[1]Manuel Serrano,Gregory J Hannon,David Beach. A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4 [J]. Nature, 1993,366: 704 ~ 707.
  • 2[2]Sherr CJ. Mammalian G1 cyclins [J]. Cell, 73:1059.
  • 3[3]Alexander Kamb, Nelleke A Gruis, Jane Weaver Feldhaus,et al.A cell cycle regulator potentially involved in genesis of many tumor types [J]. Science, 264: 436~ 439.
  • 4[4]Jean Mar. New tumor suppressor may rival p53[J]. Science,1994,264:344~345.
  • 5[5]Reed A,Califano J,Cairns P,et al. High frcquency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamouscell carcinoma [J]. Cancer Res, 1996,56: 3630~ 3633.
  • 6[6]Tsutomu Nobori, Kaoru Miura, David J Wu, et al. Deletions ofthe cyclin-dependent kinase-4 inhibitor gene in multiple humancancers [J]. Nature, 19944,368: 753~ 756.
  • 7[7]Aikou Okamoto, Douglas J Demetrick, Elisa A Spillare, et al.Mutations and altered expression of p16INK4 in human cancer[J]. Proc Natl Acad Sci USA, 1994,91 : 11045~ 11049.
  • 8李巍,国外医学.遗传学分册,1996年,19卷,5期,237页

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部